Dr Jiang joined our Board at the time of the Series B funding round in March 2021. He is Chief Strategy Officer of XtalPi, where he bears primary responsibility for the company’s strategy development including identification of growth opportunities, strategic planning and execution.
Dr Jiang joined Xtalpi with over twenty years of scientific and research management experience, most of it gained in positions of increasing responsibility at Genzyme and then Sanofi-Genzyme. Prior to joining XtalPi, he was the director of Asia R&D Strategy of the Sanofi-Genzyme R&D Center and in that capacity, he was responsible for the development of Genzyme Asia/China R&D strategy and led cross-functional R&D external collaborations and projects in Asia.
Dr. Jiang received his medical degree and doctorate in molecular biology followed by post-doctoral research in hematology and oncology at Brigham & Women's Hospital, Harvard Medical School.